146 related articles for article (PubMed ID: 18307839)
21. [Patient preference survey on the lack of taste and odor of Nasonex nasal spray. Which impact on compliance to treatment?].
Klossek JM; Serrano E; Dreyfus I; Mesbah K; Demoly P
Rev Laryngol Otol Rhinol (Bord); 2008; 129(1):35-41. PubMed ID: 18777767
[TBL] [Abstract][Full Text] [Related]
22. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
23. The impact and treatment of allergic rhinitis in the Middle East: a comparison with the landmark allergy surveys from other worldwide regions.
Hadi UH; Rahman HA
Am J Rhinol Allergy; 2013; 27(6):490-4. PubMed ID: 24070203
[TBL] [Abstract][Full Text] [Related]
24. Insights on allergic rhinitis from the patient perspective.
Fromer LM; Ortiz G; Ryan SF; Stoloff SW
J Fam Pract; 2012 Feb; 61(2 Suppl):S16-22. PubMed ID: 22312620
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.
Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Shah T
J Allergy Clin Immunol; 2006 Nov; 118(5):1142-8. PubMed ID: 17088141
[TBL] [Abstract][Full Text] [Related]
26. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
Khanna P; Shah A
Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
[TBL] [Abstract][Full Text] [Related]
27. The burden of allergic rhinitis.
Nathan RA
Allergy Asthma Proc; 2007; 28(1):3-9. PubMed ID: 17390749
[TBL] [Abstract][Full Text] [Related]
28. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
Kalpaklioglu AF; Kavut AB
Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
[TBL] [Abstract][Full Text] [Related]
29. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
30. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
[TBL] [Abstract][Full Text] [Related]
32. Managing rhinitis: Strategies for improved patient outcomes.
Carr WW; Nelson MR; Hadley JA
Allergy Asthma Proc; 2008; 29(4):349-57. PubMed ID: 18702880
[TBL] [Abstract][Full Text] [Related]
33. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate.
van Drunen C; Meltzer EO; Bachert C; Bousquet J; Fokkens WJ
Allergy; 2005; 60 Suppl 80():5-19. PubMed ID: 15948774
[TBL] [Abstract][Full Text] [Related]
34. Azelastine and fluticasone nasal spray: any advantage?
Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of allergic rhinitis].
Tas E; Bircher AJ
Ther Umsch; 2001 May; 58(5):309-14. PubMed ID: 11407233
[TBL] [Abstract][Full Text] [Related]
36. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
Patel D; Garadi R; Brubaker M; Conroy JP; Kaji Y; Crenshaw K; Whitling A; Wall GM
Allergy Asthma Proc; 2007; 28(5):592-9. PubMed ID: 18034980
[TBL] [Abstract][Full Text] [Related]
37. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
[TBL] [Abstract][Full Text] [Related]
39. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.
Marple BF; Fornadley JA; Patel AA; Fineman SM; Fromer L; Krouse JH; Lanier BQ; Penna P;
Otolaryngol Head Neck Surg; 2007 Jun; 136(6 Suppl):S107-24. PubMed ID: 17512862
[TBL] [Abstract][Full Text] [Related]
40. Respiratory procedures. Part 6--Use of nasal sprays in allergic rhinitis.
Burns D
Nurs Times; 2007 Sep 11-17; 103(37):24-5. PubMed ID: 17902591
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
